Alpha Centric Advisors LLC ARRIVENT BIOPHARMA INC Transaction History
Alpha Centric Advisors LLC
- $118 Million
- Q3 2024
Number of Shares
15,000
Previous 86,000
82.56%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%